cyclic peptideTherapeutic Peptides
Voclosporin (Lupkynis)
A novel calcineurin inhibitor derived from cyclosporine A. FDA-approved for lupus nephritis (2021). Modified at amino acid 1 for more predictable pharmacokinetics, eliminating need for therapeutic drug monitoring.
immunosuppressionlupus-nephritiscalcineurin-inhibitorFDA-approved
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
ESI-MS (computed)
Batch Info
Latest Batch—
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity dataLab Reports
0 reports on file
Summary
A novel calcineurin inhibitor derived from cyclosporine A. FDA-approved for lupus nephritis (2021). Modified at amino acid 1 for more predictable pharmacokinetics, eliminating need for therapeutic dru…